Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT00585195
Title A Study Of Oral PF-02341066, A C-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer (PROFILE 1001)
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Pfizer
Indications

anaplastic large cell lymphoma

lymphoma

Advanced Solid Tumor

lung non-small cell carcinoma

Therapies

Crizotinib + Itraconazole

Crizotinib + Rifampin

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST